# Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection

> **NCT02485509** · PHASE1,PHASE2 · COMPLETED · sponsor: **Viriom** · enrollment: 28 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** VM-1500/Placebo

## Key facts

- **NCT ID:** NCT02485509
- **Lead sponsor:** Viriom
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02485509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02485509, "Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02485509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*